MRNA logo

Moderna, Inc. (MRNA) Operating Profit

Annual Operating Profit:

-$3.94B+$294.00M(+6.94%)
December 31, 2024

Summary

  • As of today (October 8, 2025), MRNA annual operating income is -$3.94 billion, with the most recent change of +$294.00 million (+6.94%) on December 31, 2024.
  • During the last 3 years, MRNA annual operating profit has fallen by -$17.24 billion (-129.67%).
  • MRNA annual operating profit is now -129.67% below its all-time high of $13.30 billion, reached on December 31, 2021.

Performance

MRNA Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAincome statement metrics

Quarterly Operating Profit:

-$907.00M+$143.00M(+13.62%)
June 30, 2025

Summary

  • As of today (October 8, 2025), MRNA quarterly operating income is -$907.00 million, with the most recent change of +$143.00 million (+13.62%) on June 30, 2025.
  • Over the past year, MRNA quarterly operating profit has increased by +$456.00 million (+33.46%).
  • MRNA quarterly operating profit is now -116.77% below its all-time high of $5.41 billion, reached on December 31, 2021.

Performance

MRNA Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAincome statement metrics

TTM Operating Profit:

-$3.27B+$456.00M(+12.23%)
June 30, 2025

Summary

  • As of today (October 8, 2025), MRNA TTM operating income is -$3.27 billion, with the most recent change of +$456.00 million (+12.23%) on June 30, 2025.
  • Over the past year, MRNA TTM operating profit has increased by +$1.36 billion (+29.39%).
  • MRNA TTM operating profit is now -120.13% below its all-time high of $16.26 billion, reached on March 31, 2022.

Performance

MRNA TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRNAincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

MRNA Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+6.9%+33.5%+29.4%
3Y3 Years-129.7%-137.1%-120.9%
5Y5 Years-622.5%-643.4%-429.7%

MRNA Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-129.7%+6.9%-157.4%+54.9%-124.7%+36.3%
5Y5-Year-129.7%+6.9%-116.8%+54.9%-120.1%+36.3%
All-TimeAll-Time-129.7%+6.9%-116.8%+54.9%-120.1%+36.3%

MRNA Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$907.00M(+13.6%)
-$3.27B(+12.2%)
Mar 2025
-
-$1.05B(+15.7%)
-$3.73B(+5.5%)
Dec 2024
-$3.94B(+6.9%)
-$1.25B(-1680.0%)
-$3.94B(-46.5%)
Sep 2024
-
-$70.00M(+94.9%)
-$2.69B(+41.9%)
Jun 2024
-
-$1.36B(-7.7%)
-$4.63B(+9.8%)
Mar 2024
-
-$1.27B(>-9900.0%)
-$5.14B(-21.2%)
Dec 2023
-$4.24B(-145.0%)
$6.00M(+100.3%)
-$4.24B(-59.1%)
Sep 2023
-
-$2.01B(-7.8%)
-$2.67B(-619.5%)
Jun 2023
-
-$1.87B(-410.1%)
$513.00M(-89.4%)
Mar 2023
-
-$366.00M(-123.2%)
$4.83B(-48.8%)
Dec 2022
$9.42B(-29.2%)
$1.58B(+35.5%)
$9.42B(-28.9%)
Sep 2022
-
$1.17B(-52.3%)
$13.25B(-15.3%)
Jun 2022
-
$2.45B(-42.1%)
$15.64B(-3.8%)
Mar 2022
-
$4.23B(-21.9%)
$16.26B(+22.3%)
Dec 2021
$13.30B(+1842.6%)
$5.41B(+52.1%)
$13.30B(+74.7%)
Sep 2021
-
$3.56B(+16.2%)
$7.61B(+99.3%)
Jun 2021
-
$3.06B(+141.9%)
$3.82B(+502.2%)
Mar 2021
-
$1.27B(+560.4%)
$634.00M(+183.1%)
Dec 2020
-$763.00M(-39.7%)
-$275.00M(-17.0%)
-$763.00M(-23.5%)
Sep 2020
-
-$235.00M(-92.6%)
-$617.89M(-20.3%)
Jun 2020
-
-$122.00M(+6.9%)
-$513.65M(+4.1%)
Mar 2020
-
-$131.00M(-0.9%)
-$535.36M(+1.9%)
Dec 2019
-$546.00M(-32.1%)
-$129.89M(+0.7%)
-$546.00M(+4.1%)
Sep 2019
-
-$130.76M(+9.0%)
-$569.14M(-8.6%)
Jun 2019
-
-$143.71M(-1.5%)
-$524.20M(-9.8%)
Mar 2019
-
-$141.64M(+7.4%)
-$477.50M(-15.5%)
Dec 2018
-$413.27M(-53.4%)
-$153.03M(-78.3%)
-$413.27M(-36.8%)
Sep 2018
-
-$85.82M(+11.5%)
-$302.06M(-39.0%)
Jun 2018
-
-$97.02M(-25.3%)
-$217.28M(-79.3%)
Mar 2018
-
-$77.40M(-85.0%)
-$121.21M(-170.7%)
Dec 2017
-$269.36M(-20.4%)
-$41.83M(-3937.5%)
-$44.78M(-1228.9%)
Sep 2017
-
-$1.04M(-9.2%)
-$3.37M(-38.6%)
Jun 2017
-
-$948.90K(+1.9%)
-$2.43M(-50.9%)
Mar 2017
-
-$967.30K(-131.7%)
-$1.61M(-112.6%)
Dec 2016
-$223.77M(-5509.7%)
-
-
Dec 2016
-
-$417.40K(-327.2%)
-$757.70K(+21.1%)
Sep 2016
-
-$97.70K(+23.9%)
-$960.30K(+49.3%)
Jun 2016
-
-$128.40K(-12.4%)
-$1.89M(+32.0%)
Mar 2016
-
-$114.20K(+81.6%)
-$2.79M(+30.1%)
Dec 2015
-$3.99M(-13.3%)
-$620.00K(+39.9%)
-$3.99M(+1.5%)
Sep 2015
-
-$1.03M(-1.0%)
-$4.05M(+12.4%)
Jun 2015
-
-$1.02M(+22.3%)
-$4.62M(-8.2%)
Mar 2015
-
-$1.31M(-93.7%)
-$4.27M(-21.4%)
Dec 2014
-$3.52M(-864.4%)
-$679.00K(+57.7%)
-$3.52M(-24.9%)
Sep 2014
-
-$1.61M(-139.5%)
-$2.82M(-159.2%)
Jun 2014
-
-$671.00K(-19.2%)
-$1.09M(-80.6%)
Mar 2014
-
-$563.00K(-2547.8%)
-$602.00K(-64.9%)
Dec 2013
-$365.00K(+94.1%)
$23.00K(-81.5%)
-$365.00K(+78.2%)
Sep 2013
-
$124.00K(+166.7%)
-$1.67M(+18.1%)
Jun 2013
-
-$186.00K(+42.9%)
-$2.04M(+14.3%)
Mar 2013
-
-$326.00K(+74.6%)
-$2.38M(+61.6%)
Dec 2012
-$6.20M(+64.7%)
-$1.28M(-424.5%)
-$6.20M(+17.7%)
Sep 2012
-
-$245.00K(+53.5%)
-$7.54M(+36.2%)
Jun 2012
-
-$527.00K(+87.3%)
-$11.81M(+29.2%)
Mar 2012
-
-$4.14M(-58.2%)
-$16.68M(+5.1%)
Dec 2011
-$17.57M(+32.4%)
-$2.62M(+42.0%)
-$17.57M(+6.4%)
Sep 2011
-
-$4.52M(+16.1%)
-$18.76M(+23.6%)
Jun 2011
-
-$5.39M(-7.0%)
-$24.57M(+2.0%)
Mar 2011
-
-$5.04M(-32.2%)
-$25.07M(+3.6%)
Dec 2010
-$26.00M(-154.0%)
-$3.81M(+63.1%)
-$26.00M(+4.9%)
Sep 2010
-
-$10.33M(-75.3%)
-$27.34M(-15.1%)
Jun 2010
-
-$5.89M(+1.4%)
-$23.75M(+1.6%)
Mar 2010
-
-$5.97M(-16.0%)
-$24.14M(-135.8%)
Dec 2009
-$10.24M
-$5.15M(+23.5%)
-$10.24M(+40.3%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$6.73M(-7.2%)
-$17.14M(+15.1%)
Jun 2009
-
-$6.28M(-179.2%)
-$20.18M(+28.3%)
Mar 2009
-
$7.93M(+165.8%)
-$28.13M(+44.5%)
Dec 2008
-$50.69M(+7.1%)
-$12.05M(-23.2%)
-$50.69M(+0.5%)
Sep 2008
-
-$9.78M(+31.3%)
-$50.95M(+12.4%)
Jun 2008
-
-$14.23M(+2.7%)
-$58.13M(-2.1%)
Mar 2008
-
-$14.63M(-18.8%)
-$56.93M(-4.4%)
Dec 2007
-$54.53M(-86.0%)
-$12.31M(+27.4%)
-$54.53M(-2.3%)
Sep 2007
-
-$16.97M(-30.2%)
-$53.32M(-19.1%)
Jun 2007
-
-$13.03M(-6.6%)
-$44.75M(-36.1%)
Mar 2007
-
-$12.23M(-10.2%)
-$32.88M(-12.1%)
Dec 2006
-$29.32M(+13.3%)
-$11.10M(-32.2%)
-$29.32M(-5.8%)
Sep 2006
-
-$8.40M(-628.4%)
-$27.70M(+2.9%)
Jun 2006
-
-$1.15M(+86.7%)
-$28.55M(+20.9%)
Mar 2006
-
-$8.67M(+8.6%)
-$36.08M(-6.8%)
Dec 2005
-$33.80M(-18.6%)
-$9.48M(-2.7%)
-$33.80M(-11.8%)
Sep 2005
-
-$9.24M(-6.3%)
-$30.24M(-6.0%)
Jun 2005
-
-$8.69M(-36.1%)
-$28.52M(-4.6%)
Mar 2005
-
-$6.39M(-7.9%)
-$27.27M(+4.3%)
Dec 2004
-$28.49M(-358.7%)
-$5.92M(+21.3%)
-$28.49M(+0.0%)
Sep 2004
-
-$7.53M(-1.2%)
-$28.50M(-4.7%)
Jun 2004
-
-$7.44M(+2.1%)
-$27.22M(-147.9%)
Mar 2004
-
-$7.60M(-28.1%)
-$10.98M(-76.8%)
Dec 2003
-$6.21M(+52.2%)
-$5.93M(+5.0%)
-$6.21M(-15.5%)
Sep 2003
-
-$6.25M(-171.0%)
-$5.38M(-106.1%)
Jun 2003
-
$8.80M(+410.7%)
-$2.61M(+79.9%)
Mar 2003
-
-$2.83M(+44.5%)
-$12.96M(+0.2%)
Dec 2002
-$12.99M(-36.0%)
-$5.10M(-46.6%)
-$12.99M(-18.3%)
Sep 2002
-
-$3.48M(-124.1%)
-$10.98M(-16.9%)
Jun 2002
-
-$1.55M(+45.8%)
-$9.40M(+6.1%)
Mar 2002
-
-$2.86M(+7.4%)
-$10.01M(-4.8%)
Dec 2001
-$9.55M(+7.6%)
-$3.09M(-63.2%)
-$9.55M(+5.9%)
Sep 2001
-
-$1.89M(+12.4%)
-$10.15M(-0.5%)
Jun 2001
-
-$2.16M(+10.0%)
-$10.11M(+2.5%)
Mar 2001
-
-$2.40M(+35.0%)
-$10.36M(-0.3%)
Dec 2000
-$10.34M(-9.3%)
-$3.69M(-99.9%)
-$10.34M(+2.4%)
Sep 2000
-
-$1.85M(+23.5%)
-$10.59M(+1.1%)
Jun 2000
-
-$2.42M(-1.8%)
-$10.71M(-7.2%)
Mar 2000
-
-$2.38M(+39.9%)
-$9.99M(+0.2%)
Dec 1999
-$9.45M(-301.9%)
-$3.95M(-101.5%)
-$10.02M(-17.6%)
Sep 1999
-
-$1.96M(-15.4%)
-$8.51M(-24.3%)
Jun 1999
-
-$1.70M(+29.2%)
-$6.85M(-28.0%)
Mar 1999
-
-$2.40M(+2.1%)
-$5.35M(-69.8%)
Dec 1998
-$2.35M(+60.8%)
-$2.45M(-717.3%)
-$3.15M(-1.7%)
Sep 1998
-
-$300.00K(-50.0%)
-$3.10M(+31.1%)
Jun 1998
-
-$200.00K(0.0%)
-$4.50M(+19.6%)
Mar 1998
-
-$200.00K(+91.7%)
-$5.60M(+8.2%)
Dec 1997
-$6.00M(-1100.0%)
-$2.40M(-41.2%)
-$6.10M(-64.9%)
Sep 1997
-
-$1.70M(-30.8%)
-$3.70M(-85.0%)
Jun 1997
-
-$1.30M(-85.7%)
-$2.00M(-300.0%)
Mar 1997
-
-$700.00K(>-9900.0%)
-$500.00K(>-9900.0%)
Dec 1996
-$500.00K(-400.0%)
-
-
Sep 1996
-
$0.00(-100.0%)
$0.00(+100.0%)
Jun 1996
-$100.00K(0.0%)
$200.00K(+100.0%)
-$100.00K(+66.7%)
Mar 1996
-
$100.00K(+133.3%)
-$300.00K(+25.0%)
Dec 1995
-
-$300.00K(-200.0%)
-$400.00K(-100.0%)
Sep 1995
-
-$100.00K(>-9900.0%)
-$200.00K(>-9900.0%)
Jun 1995
-$100.00K(-150.0%)
$0.00(0.0%)
$0.00(-100.0%)
Mar 1995
-
$0.00(+100.0%)
$100.00K(>+9900.0%)
Dec 1994
-
-$100.00K(-200.0%)
$0.00(-100.0%)
Sep 1994
-
$100.00K(0.0%)
$200.00K(0.0%)
Jun 1994
$200.00K
$100.00K(+200.0%)
$200.00K(+100.0%)
Mar 1994
-
-$100.00K(-200.0%)
$100.00K(-50.0%)
Dec 1993
-
$100.00K(0.0%)
$200.00K(+100.0%)
Sep 1993
-
$100.00K
$100.00K

FAQ

  • What is Moderna, Inc. annual operating income?
  • What is the all-time high annual operating profit for Moderna, Inc.?
  • What is Moderna, Inc. annual operating profit year-on-year change?
  • What is Moderna, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Moderna, Inc.?
  • What is Moderna, Inc. quarterly operating profit year-on-year change?
  • What is Moderna, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Moderna, Inc.?
  • What is Moderna, Inc. TTM operating profit year-on-year change?

What is Moderna, Inc. annual operating income?

The current annual operating profit of MRNA is -$3.94B

What is the all-time high annual operating profit for Moderna, Inc.?

Moderna, Inc. all-time high annual operating income is $13.30B

What is Moderna, Inc. annual operating profit year-on-year change?

Over the past year, MRNA annual operating income has changed by +$294.00M (+6.94%)

What is Moderna, Inc. quarterly operating income?

The current quarterly operating profit of MRNA is -$907.00M

What is the all-time high quarterly operating profit for Moderna, Inc.?

Moderna, Inc. all-time high quarterly operating income is $5.41B

What is Moderna, Inc. quarterly operating profit year-on-year change?

Over the past year, MRNA quarterly operating income has changed by +$456.00M (+33.46%)

What is Moderna, Inc. TTM operating income?

The current TTM operating profit of MRNA is -$3.27B

What is the all-time high TTM operating profit for Moderna, Inc.?

Moderna, Inc. all-time high TTM operating income is $16.26B

What is Moderna, Inc. TTM operating profit year-on-year change?

Over the past year, MRNA TTM operating income has changed by +$1.36B (+29.39%)
On this page